DERIVATIVES OF 3-[2-(3-ACYLAMINO-2-OXO-2H-PYRIDIN-1-YL)-ACETYLAMINO]-4-OXO-PENTANE ACID AND THEIR APPLICATION AS CASPASE INHIBITORS Russian patent published in 2011 - IPC C07D213/75 C07D401/06 C07D409/06 A61K31/4412 A61K31/4436 A61P9/10 A61P29/00 A61P35/00 

Abstract RU 2412936 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed invention relates to compound of formula I: where: R1 represents R6C(O)-, R6SO2-, (R6)2NC(O)-; R2 represents hydrogen, -CF3 or R8; R3 represents -T-R9; R4 represents -COOH or -COOR8; R5 represents -CH2F or -CH2O-2, 3, 5, 6 - tetrafluorophenyl; R6 represents R6a or R6b; two R6 groups, together with the atom to which they are bound optionally form 3-10-member aromatic or non-aromatic ring; and where each R6 is independently substituted with 6 substituents, independently selected from R; R6a and R6b each independently represents (C1-C3)-aliphatic group, (C6-C10)-aryl-, (C6-C10)-aryl-(C1-C12) aliphatic group; R represents halogen, -OR7, -R7; each R7 is independently selected from: hydrogen, (C1-C12)-aliphatic group, (C6-C10)-aryl; R8 represents (C1-C12)-aliphatic group; T represents direct bond or (C1-C6)-aliphatic group, where to 2 aliphatic carbon atoms in T can be optionally substituted with O; R9 is optionally substituted (C6-C10)-aryl or (C5-C10) - heteroaryl, invention also relates to pharmaceutical composition, to methods of treatment, inhibition of caspase-mediated processes, to method of cell preservation with application of formula I compounds application of such compositions for treatment of caspase-mediated diseases and to methods of obtaining formula I compounds.

EFFECT: obtained and described are novel compounds, which can be useful in treatment of caspase-mediated diseases.

38 cl, 22 ex

Similar patents RU2412936C2

Title Year Author Number
CASPASE INHIBITORS AND USE THEREOF 2004
  • Brenchli Gaj
  • Sharr'Er Zhan-Dam'En
  • Darrant Stiven
  • Negtel Ronal'D
  • Mortimor Majkl
  • Stadli Dzhon R.
RU2372335C2
SUBSTITUTED DERIVATIVES OF PURINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL PREPARATION 1997
  • Pejman Anushirvan
  • Knolle Jokhen
  • Vener Fol'Kmar
  • Brajpol' Gerkhard
  • Gurvest Zhan-Fransua
  • Karniato Deni
  • Gadek Tomas Richard
RU2228335C2
NEW CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTINE RECEPTOR 1997
  • Fol'Kmar Vener
  • Jokhen Knolle
  • Khans Ul'Rikh Shtilts
  • Zhan-Fransua Gurve
  • Deni Karniato
  • Tomas Richard Gadek
  • Robert Makdauehll
  • Robert Moris Pitti
  • Sara Kehtrin Boudari
RU2180331C2
INHIBITORS OF SERINE PROTEASES, IN PARTICULAR, HC-3-HC4A PROTEASE 2004
  • Britt Shon D.
  • Kottrell Kevin M.
  • Perni Robert B.
  • Pitlik Janosh
RU2412198C2
SUBSTITUTED 2-OXO- AND 2- THIOXO- DIHYDROQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS 2011
  • Kjunert Sven
  • Barenberg Gregor
  • Kless Akhim
  • Shreder Volfgang
RU2581362C2
SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES AS Rho-KINASE INHIBITORS 2007
  • Plettenburg Oliver
  • Khofmajster Armin
  • Brendel' Joakhim
  • Len Mattias
RU2455302C2
METHODS AND INTERMEDIATE PRODUCTS 2005
  • Tehnauri Dzheral'D Dzh.
  • Chen' Min'Chzhan
  • Dzhouns Ehndrju D.
  • Najs Filip L.
  • Trjudo Martehn
  • Gerin Dehvid Dzh.
  • Snunian Dzhon R.
RU2433127C2
CASPASE INHIBITOR PRODRUGS 2006
  • Darrant Stiven
  • Sharr'Er Zhan-Dam'En
  • Stadli Dzhon
RU2427582C2
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES 2014
  • Tanis Steven P.
  • Larsen Scott D.
  • Artman Gerald D. Iii
  • Parker Timothy
RU2687490C2
ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION 1994
  • Uitajak Dzhon
  • Z'Ju Chu-Bajao
  • Sileki-Dzurdz Tais Motria
  • Olson Richard Ehrik
  • Degrado Uill'Jam Frehnk
  • Kejn Gehri Ehjvonn
  • Vatt Duglas Gaj
  • Pinto Donald
RU2149871C1

RU 2 412 936 C2

Authors

Sharr'E Zhan-Dam'En

Negtel Ronal'D

Mortimor Majkl

Stadli Dzhon R.

Dates

2011-02-27Published

2005-11-21Filed